<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211225053512N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-12-07</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effectiveness of pharmacological and non-pharmacological methods of reducing pain in retinopathy of prematurity examination</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effectiveness of pharmacological and non-pharmacological methods of reducing pain in retinopathy of prematurity examination</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-12-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>300</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/63345</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: According to the definition of the World Health Organization, babies who are born before the 37th week from the first day of the last menstrual period are considered premature, Randomization description: Random sampling based on the table of random numbers (at least 100 babies in each group).Allocation of patients in two groups was done by random block allocation method. The allocation sequence was generated using the free web-based system https://www.sealedenvelope.com/. To produce the sequence, the number of subjects in each block is 6 and 4, and letters A are for the intervention group and letters B are considered for the control group. Finally, 200 samples (24 blocks of 6 and 14 blocks of 4) have been produced in two groups A and B, Blinding description: In this study, Double Blinde Randomized Control Trial (double blind clinical trial), We decided to put eligible infants in three groups of ketamine and fentanyl and non-pharmacological methods and compare their effectiveness in preventing pain. At least 100 babies in each group are included in the study based on the inclusion criteria and are randomly assigned to three treatment groups. Then, treatment groups are compared based on PIPP (premature infant pain index) which is measured by someone other than a nurse.</study_design>
      <phase>3</phase>
      <hc_freetext>Pain reduction in the eye examination of premature babies..</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: The non-pharmacological group of SADDLING babies - pacifiers and oral sucrose 25% half cc per kilogram of weight. Intervention 2: Intervention group 2: Ketamine 2mg/kg nasally is given to the patient thirty minutes before each examination by the nurse. Before pouring the ketamine drugs, the noses are suctioned and cleaned by pouring a drop of normal saline, and the drops are poured 5 minutes later. Intervention 3: Intervention group 3: Fentanyl  2 µg/kg nasally is given to the patient thirty minutes before each examination by the nurse. Before pouring the ketamine drugs, the noses are suctioned and cleaned by pouring a drop of normal saline, and the drops are poured 5 minutes later. Intervention 4: Intervention group 4: Acetaminophen 2 drops/kg orally is given to the patient thirty minutes before each examination by the nurse. Before pouring the ketamine drugs, the noses are suctioned and cleaned by pouring a drop of normal saline, and the drops are poured 5 minutes later.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Only a part of the data, such as the information related to the main result or the like, can be shared.

When:
The access period starts 6 months after the results are published.

To whom:
It will be available only to researchers working in academic and scientific institutions.

Conditions:
It will be available only for researchers working in academic and scientific institutions after the official approval of the supervisor and main supervisor, and other personal analyzes are not allowed.

Where to obtain:
Mrs. Dr. Maryam Khoshnood Shariati  Mahdieh Hospital Tehran

How to obtain:
Visiting in person or calling Dr. Maryam Khoshnoud Shariati at Mahdieh Hospital in Tehran and registering a legal request at the Vice-Chancellor of Education at Mahdieh Hospital.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hamed Razi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mahdieh Hospital., Shahid Rajabnia Street., Shishagar Alley., Fadaiyan Islam Street., Shush Street., Tehran., Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1185817311</zip>
        <telephone>+98 21 5506 2628</telephone>
        <email>mahdiyeh_hospital@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Maryam Khoshnoud Shariati</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mahdieh Hospital., Shahid Rajabnia Street., Shishagar Alley., Fadaiyan Islam Street., Shush Street., Tehran., Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1185817311</zip>
        <telephone>+98 21 5506 2628</telephone>
        <email>mahdiyeh_hospital@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Be hemodynamically stable
Be alert
And be able to tolerate 25% oral sucrose
At least one hour has passed since the feeding
The examination will also be done before the next meal</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>37 months</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The baby of an addicted mother
Taking sedative before examination
Connected to the ventilator</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: The non-pharmacological group of SADDLING babies - pacifiers and oral sucrose 25% half cc per kilogram of weight.</i_keyword>
      <i_keyword>Intervention group 2: Ketamine 2mg/kg nasally is given to the patient thirty minutes before each examination by the nurse. Before pouring the ketamine drugs, the noses are suctioned and cleaned by pouring a drop of normal saline, and the drops are poured 5 minutes later.</i_keyword>
      <i_keyword>Intervention group 3: Fentanyl  2 µg/kg nasally is given to the patient thirty minutes before each examination by the nurse. Before pouring the ketamine drugs, the noses are suctioned and cleaned by pouring a drop of normal saline, and the drops are poured 5 minutes later.</i_keyword>
      <i_keyword>Intervention group 4: Acetaminophen 2 drops/kg orally is given to the patient thirty minutes before each examination by the nurse. Before pouring the ketamine drugs, the noses are suctioned and cleaned by pouring a drop of normal saline, and the drops are poured 5 minutes later.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Gestational age. Timepoint: After the examination, the vital signs are monitored for 24 hours. Method of measurement: Premature infant pain profile.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-04-25</approval_date>
        <contact_name>Vice President of Research and Technology Shahid Beheshti University of Medical Sciences.</contact_name>
        <contact_address>Mahdieh Hospital., Shahid Rajabnia Street., Shishagar Alley., Fadaiyan Islam Street., Shush Street., Tehran., Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
